Global PH Consult

Alex Kantorovich is currently a Pulmonary Hypertension Senior Medical Science Liaison at United Therapeutics. Prior to this role, he served as a Clinical Associate Professor of Pharmacy Practice at Chicago State University College of Pharmacy and Clinical Pharmacy Specialist at Advocate Christ Medical Center. He completed his Doctor of Pharmacy degree at the University of Illinois-Chicago and went on to complete a Pharmacotherapy Residency at Cleveland Clinic focusing on cardiology and critical care. He is a Board-Certified Pharmacotherapy Specialist.

Paresh Giri has dedicated much of his professional career to improving the lives of patients living with pulmonary hypertension. He founded the Pulmonary Hypertension Program at Loma Linda University Medical Centre, CA, USA and led its evolution into a Pulmonary Hypertension Association-accredited Regional Clinical Program. Beyond clinical practice, he volunteers extensively with leading pulmonary vascular organizations, serving on the Pulmonary Hypertension Association Care Centre (PHCC) Review Committee , CHEST Pulmonary Vascular Disease Network and the Pulmonary Vascular Research Institute Access to Care Workstream, where he helps advance standards of care and expand access to specialised PH services. Paresh is widely recognised for his educational contributions, delivering invited lectures at CHEST Annual Meetings and the Pulmonary Hypertension Association conferences. His research has produced numerous peer-reviewed publications in pulmonary hypertension and pulmonary vascular disease, with recent work emphasising patient-centred care, shared decision-making, and quality-of-life outcomes. Through his leadership, scholarship, and volunteer service, Paresh continues to champion innovation, collaboration, and compassionate care for individuals affected by pulmonary hypertension.

Sandeep Sahay is the director of the pulmonary hypertension program at the Houston Methodist Hospital. He plays active role in the global professional societies. He serves as co chair of the IDDI with PVRI  and serves on leadership committees for the American Thoracic Society and Pulmonary Hypertension Association. He is also Associate Editor for Pulmonary Circulation and Respiratory Medicine, and has published widely in PH. He is passionate about teaching, collaboration, and improving care for people living with PH and advanced lung diseases. Outside work, he enjoys music, travel, and time with his family.

Prashant Bobhate is a Consultant Paediatric Cardiologist and Pulmonary Hypertension specialist at Kokilaben Dhirubhai Ambani Hospital, Mumbai, India. After completing his paediatric cardiology training at Escorts Heart Institute, New Delhi, he pursued advanced fellowship training in Pulmonary Hypertension at the Stollery Children’s Hospital and Mazankowski Alberta Heart Institute, University of Alberta, Canada.

Prashant has established a national reputation in pulmonary vascular disease and congenital heart disease, with particular expertise in advanced transcatheter therapies for pulmonary hypertension. He leads several multicentre clinical and translational research initiatives, including investigator-initiated studies on pulmonary arterial hypertension, artificial intelligence-based digital auscultation for congenital heart disease, and novel therapeutic approaches. He is the lead author of the Indian Consensus Statement on the Evaluation and Management of Pulmonary Arterial Hypertension and has authored more than 45 peer-reviewed publications and multiple book chapters.

An active educator and invited faculty at national and international scientific meetings, Prashant is committed to advancing collaborative research, education, and equitable access to high-quality pulmonary vascular care. His work focuses on developing pragmatic, evidence-based strategies that improve outcomes for patients with pulmonary hypertension, particularly in low- and middle-income healthcare settings.